QUIA — QUIA PHARMA AB (publ) Share News
0.000.00%
- SEK2.19m
- SEK2.19m
Brief: QuiaPEG Raises SEK 28.4 Mln Through Rights Issue Of Units
Brief: QuiaPEG Pharmaceuticals Cancels Planned Rights Issue Of Units
Brief: Quiapeg Pharmaceuticals Q4 Operating Loss At SEK 6.4 Mln
Brief: Quiapeg Pharmaceuticals Holding Proposes Rights Issue Of Units At Sek 38.4 Mln
Brief: QuiaPEG Gets SEK 7 Mln Through Exercise Of Warrants And Directed Share Issue
Brief: Quiapeg Pharmaceuticals Q3 Oper Loss Narrows To SEK 4.1 Mln
Brief: QuiaPEG Q2 Operating Loss Narrows To SEK 3.9 Mln
Brief: Quiapeg Pharmaceuticals Holding AB And Nils Owe Engström Agreed To Terminate Current Assignment Agreement
Brief: Quiapeg: Positive Results From Study Of Qpg-1030
Brief: QuiaPEG Consortium Consisting Of Board Members, CEO And CMO Buy Remaining Shares Of Previous Major External Shareholder
Brief: QuiaPEG Pharmaceuticals Holding Repays Convertible Loan Of About SEK 8 Mln
Brief: Quiapeg Pharmaceuticals Q1 Operating Loss Narrows To SEK 3.3 Million
Brief: Quiapeg Pharmaceuticals: Positive Results From Preclinical Study Of QPG-1030
Brief: Quiapeg Q4 Operating Loss Unchanged At SEK 6 Mln
Brief: QuiaPEG Pharmaceuticals Holding Raises About SEK 6.2 Mln Through Exercise Of Warrants
Brief: QuiaPEG: First Day Of Trading On Nasdaq First North Growth Market Expected To Be Aug 21, 2020
Brief: Quiapeg To Be Listed On Nasdaq First North
Brief: QuiaPEG Raises Proceeds Of About SEK 37.6 Mln Through Rights Issue
Brief: QuiaPEG Pharmaceuticals Holding Gets USD 200,000 From Chengdu Shengnuo Biopharm Co